News

By Priscila Mayumi Kashiwabara

Updates regarding public hearing about guidelines for the Examination of Patent Applications in the Biotechnology field

As informed on our Newsletter #03, on February 2019, the BRPTO started public hearing proceedings regarding the revised Guidelines for the Examination of Patent Applications in the Biotechnology Field. Now, on June 06, 2020, the BRPTO published the final revised version, which incorporated some of the suggestions submitted during the public hearings. The revised version comprises mainly few minor textual corrections and changes to make the text clearer.
 
For further information, click below to access our full newsletter.
Back

Last by Priscila Mayumi Kashiwabara

December 29, 2021

Sequence listing in ST.26 format is officially postponed until July 1, 2022 by the Brazilian PTO

On December 28, 2021, the BRPTO published, by means of the Official Gazette nº 2660, the Ordinance #56/2021, which establishes the procedures Sequence listing in ST.26 format is officially postponed until July 1, 2022 by the Brazilian PTO

Ler notícia

July 5, 2021

Personalised medicine in Brazil: IP and regulatory challenges

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first Personalised medicine in Brazil: IP and regulatory challenges

Ler notícia

March 30, 2021

Brazilian PTO extends the Patent Backlog Fighting Project

Continuing with the goal of reducing the number of patent applications pending decision, the Brazilian PTO (“BPTO”) published the Ordinance/INPI/PR N° 21, Brazilian PTO extends the Patent Backlog Fighting Project

Ler notícia